Back to Results
First PageMeta Content
Clinical research / Pharmaceutical industry / Food and Drug Administration / Astex / Eisai / Decitabine / Hypomethylating agent / Clinical trial / Drug discovery / Pharmaceutical sciences / Pharmacology / Medicine


July 8, 2013 Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator Investigational New Drug (IND) Application and Data Presentations Planned for the Fourth Quarter DUBLIN,
Add to Reading List

Open Document

File Size: 13,47 KB

Share Result on Facebook
UPDATE